申请人:Seattle Genetics, Inc.
公开号:EP3505191A1
公开(公告)日:2019-07-03
Auristatin-type peptides are disclosed which are highly cytotoxic, synthetically accessible, and can be conjugated to antibodies and other ligands.
本研究公开了具有高度细胞毒性、可合成、可与抗体和其他配体连接的 Auristatin 型多肽。